The use of implantable cardioverter defibrillators in Iceland: a retrospective population based study

2.50
Hdl Handle:
http://hdl.handle.net/2336/6359
Title:
The use of implantable cardioverter defibrillators in Iceland: a retrospective population based study
Authors:
Leosdottir, Margret; Reimarsdottir, Gudrun; Gottskalksson, Gizur; Torfason, Bjarni; Vigfusdottir, Margret; Arnar, David O
Citation:
BMC Cardiovasc Disord 2006, 6:22
Issue Date:
24-May-2006
Abstract:
BACKGROUND: Indications for implantable cardioverter defibrillator (ICD) implantation have expanded considerably in recent years, resulting in steadily growing numbers of ICD recipients worldwide. The aim of this study was to review the overall experience with ICDs in Iceland. METHODS: This was a retrospective single centre study set at the University Hospital in Iceland. Data on all ICD implantations in Iceland from the first implantation in 1992 till the end of 2002 was reviewed. RESULTS: Sixty-two patients (71% male) received an ICD during this period. There was an increase in the number of implants by year and the number of new implants in 2001 and 2002 amounted to 56 and 38 per million, respectively. The mean age at implantation was 58 (+/-14) years. Forty patients (65%) had coronary artery disease. The most common indications for ICD implantation were cardiac arrest, 32 (52%) and another 26 (42%) had experienced ventricular tachycardia without cardiac arrest. The most common adverse event was inappropriate shocks. Twenty-eight patients (45%) received therapy from their ICDs, with the majority receiving appropriate therapy. Of the thirteen patients deceased before or during the study period, no case of sudden arrhythmic death was observed. CONCLUSION: This study shows that the experience with ICDs in Iceland is in most respects similar to other Western countries.
Description:
To access full text version of this article. Please click on the hyperlink "View/open" at the bottom of this page
Additional Links:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1481553

Full metadata record

DC FieldValue Language
dc.contributor.authorLeosdottir, Margret-
dc.contributor.authorReimarsdottir, Gudrun-
dc.contributor.authorGottskalksson, Gizur-
dc.contributor.authorTorfason, Bjarni-
dc.contributor.authorVigfusdottir, Margret-
dc.contributor.authorArnar, David O-
dc.date.accessioned2006-12-06T09:41:00Z-
dc.date.available2006-12-06T09:41:00Z-
dc.date.issued2006-05-24-
dc.date.submitted2006-12-06-
dc.identifier.citationBMC Cardiovasc Disord 2006, 6:22en
dc.identifier.issn1471-2261-
dc.identifier.pmid16723025-
dc.identifier.doi10.1186/1471-2261-6-22-
dc.identifier.otherCAR12-
dc.identifier.otherTAS12-
dc.identifier.urihttp://hdl.handle.net/2336/6359-
dc.descriptionTo access full text version of this article. Please click on the hyperlink "View/open" at the bottom of this pageen
dc.description.abstractBACKGROUND: Indications for implantable cardioverter defibrillator (ICD) implantation have expanded considerably in recent years, resulting in steadily growing numbers of ICD recipients worldwide. The aim of this study was to review the overall experience with ICDs in Iceland. METHODS: This was a retrospective single centre study set at the University Hospital in Iceland. Data on all ICD implantations in Iceland from the first implantation in 1992 till the end of 2002 was reviewed. RESULTS: Sixty-two patients (71% male) received an ICD during this period. There was an increase in the number of implants by year and the number of new implants in 2001 and 2002 amounted to 56 and 38 per million, respectively. The mean age at implantation was 58 (+/-14) years. Forty patients (65%) had coronary artery disease. The most common indications for ICD implantation were cardiac arrest, 32 (52%) and another 26 (42%) had experienced ventricular tachycardia without cardiac arrest. The most common adverse event was inappropriate shocks. Twenty-eight patients (45%) received therapy from their ICDs, with the majority receiving appropriate therapy. Of the thirteen patients deceased before or during the study period, no case of sudden arrhythmic death was observed. CONCLUSION: This study shows that the experience with ICDs in Iceland is in most respects similar to other Western countries.en
dc.language.isoenen
dc.publisherBioMed Centralen
dc.relation.urlhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1481553en
dc.subject.meshAdolescenten
dc.subject.meshAdulten
dc.subject.meshAgeden
dc.subject.meshAged, 80 and overen
dc.subject.meshCoronary Diseaseen
dc.subject.meshDefibrillators, Implantableen
dc.subject.meshFemaleen
dc.subject.meshHeart Arresten
dc.subject.meshHumansen
dc.subject.meshIcelanden
dc.subject.meshMaleen
dc.subject.meshMiddle Ageden
dc.subject.meshPostoperative Complicationsen
dc.subject.meshResearch Support, Non-U.S. Gov'ten
dc.subject.meshRetrospective Studiesen
dc.subject.meshSurvival Analysisen
dc.subject.meshTachycardia, Ventricularen
dc.titleThe use of implantable cardioverter defibrillators in Iceland: a retrospective population based studyen
dc.typeArticleen
dc.identifier.journalBMC cardiovascular disordersen
dc.format.digYES-

Related articles on PubMed

All Items in Hirsla are protected by copyright, with all rights reserved, unless otherwise indicated.